Veterinary Medicines

Engystol-Tabletten für Tiere

Authorised
  • SULFUR D4
  • SULFUR D10
  • VINCETOXICUM E CINERE D30
  • VINCETOXICUM HIRUNDINARIA D6
  • VINCETOXICUM HIRUNDINARIA D10
  • VINCETOXICUM HIRUNDINARIA D30
Download as PDF

Product identification

Medicine name:
Engystol-Tabletten für Tiere
Active substance:
  • SULFUR D4
  • SULFUR D10
  • VINCETOXICUM E CINERE D30
  • VINCETOXICUM HIRUNDINARIA D6
  • VINCETOXICUM HIRUNDINARIA D10
  • VINCETOXICUM HIRUNDINARIA D30
Target species:
  • Cattle
  • Dog
  • Goat
  • Sheep
  • Horse
  • Cat
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • SULFUR D4
    36.00
    milligram(s)
    /
    1.00
    Tablet
  • SULFUR D10
    36.00
    milligram(s)
    /
    1.00
    Tablet
  • VINCETOXICUM E CINERE D30
    12.00
    milligram(s)
    /
    1.00
    Tablet
  • VINCETOXICUM HIRUNDINARIA D6
    72.00
    milligram(s)
    /
    1.00
    Tablet
  • VINCETOXICUM HIRUNDINARIA D10
    72.00
    milligram(s)
    /
    1.00
    Tablet
  • VINCETOXICUM HIRUNDINARIA D30
    72.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Dog
    • Goat
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cat
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AX
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Homeopathic medicinal products (Article 19 of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Biologische Heilmittel Heel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biologische Heilmittel Heel GmbH
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 839301
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/06/2020
Updated on: 17/03/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 4/12/2019
Updated on: 17/03/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 2/03/2020
Updated on: 17/03/2025
Download

at-puar-600000091477-np-engystoeltaebletten-de.pdf

German (PDF)
Published on: 17/03/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."